C4 Therapeutics Inc (CCCC) Is Down -23.72% in 2024 With Lots of Room to Run

C4 Therapeutics Inc (NASDAQ: CCCC) is -23.72% lower on its value in year-to-date trading and has touched a low of $1.06 and a high of $11.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CCCC stock was last observed hovering at around $4.72 in the last trading session, with the day’s loss setting it -0.41%.

Currently trading at $4.31, the stock is -24.96% and -26.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.51 million and changing -8.69% at the moment leaves the stock -33.16% off its SMA200. CCCC registered 139.44% gain for a year compared to 6-month gain of -24.12%. The firm has a 50-day simple moving average (SMA 50) of $5.8874 and a 200-day simple moving average (SMA200) of $6.44845.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -32.76% loss in the last 1 month and extending the period to 3 months gives it a -31.37%, and is -28.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.19% over the week and 7.98% over the month.

C4 Therapeutics Inc (CCCC) has around 145 employees, a market worth around $277.81M and $33.67M in sales. Profit margin for the company is -313.35%. Distance from 52-week low is 306.60% and -63.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.69%).

with sales reaching $3.2M over the same period.The EPS is expected to grow by 43.74% this year, but quarterly earnings will post 69.64% year-over-year. Quarterly sales are estimated to shrink -1.87% in year-over-year returns.

C4 Therapeutics Inc (CCCC) Top Institutional Holders

161.0 institutions hold shares in C4 Therapeutics Inc (CCCC), with institutional investors hold 103.54% of the company’s shares. The shares outstanding are 60.47M, and float is at 56.67M with Short Float at 10.33%. Institutions hold 91.70% of the Float.

The top institutional shareholder in the company is LYNX1 CAPITAL MANAGEMENT LP with over 6.88 million shares valued at $31.79 million. The investor’s holdings represent 9.9993% of the CCCC Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 4.88 million shares valued at $22.54 million to account for 7.0891 of the shares outstanding. The other top investors are WASATCH ADVISORS LP which holds 4.85 million shares representing 7.0442% and valued at over $22.39 million, while BLACKROCK INC. holds 6.6146 of the shares totaling 4.55 million with a market value of $21.03 million.